Chile Cardiovascular Devices Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook 2026-2030

Chile represents one of the more mature medical device markets in Latin America, with cardiovascular products forming a sizable and steadily growing sub-segment. Public health system procurement (FONASA) and the private ISAPRE system together underpin predictable demand for diagnostic, monitoring, and therapeutic cardiac equipment. Imports continue to supply the bulk of high-value devices, while local distribution channels and hospital networks have become increasingly sophisticated.

• •2025 market value estimated at approximately USD 0.273 billion
• •Forecast compound annual growth rate of around 7.68%
• •Largely import-dependent for advanced interventional and rhythm-management devices

The principal growth drivers are demographic aging, a growing prevalence of cardiovascular risk factors such as obesity, diabetes, and hypertension, and the gradual expansion of Chile's universal health coverage to include more cardiac procedures. Investment in catheterization labs and cardiac surgery centers across Santiago and regional capitals is increasing procedure volumes. Greater use of minimally invasive techniques, including transcatheter valve interventions and electrophysiology procedures, is also lifting per-procedure device spend.

• •Aging population driving higher incidence of coronary and structural heart disease
• •Public health reforms expanding access to cardiac diagnostics and interventions
• •Hospital modernization programs adding new cath labs and surgical capacity

The market is commonly segmented by device type into diagnostic and monitoring devices (ECG, Holter, echocardiography, stress systems), therapeutic and surgical devices (stents, balloons, pacemakers, implantable cardioverter-defibrillators, heart valves, ventricular assist devices), and related cardio-thoracic surgery instruments. Therapeutic devices account for the largest revenue share, supported by procedure growth in interventional cardiology. Geographically, the Metropolitan Region (Santiago) anchors demand, with secondary growth in Valparaíso, Biobío, and Maule as regional hospitals expand cardiac services.

• •Therapeutic and interventional cardiology devices represent the largest value segment
• •Diagnostic and monitoring equipment growing fastest in primary care and outpatient settings
• •Santiago dominates consumption, with rising uptake in Biobío and Valparaíso regions

What are the recent trends and outlook?

Near-term trends point to wider adoption of transcatheter valve replacement, left atrial appendage closure, and advanced electrophysiology ablation, alongside broader use of remote cardiac monitoring in ambulatory and home settings. Data integration between imaging, EMR, and cath lab systems is accelerating as hospitals digitalize. Over the forecast horizon, the market is expected to continue outpacing the wider Chilean medtech sector, supported by stable reimbursement, ongoing hospital investment, and a steady pipeline of next-generation device approvals.

• •Structural heart and electrophysiology procedures are the fastest-growing clinical areas
• •Remote and wearable cardiac monitoring expanding beyond hospitals into home care
• •Continued double-digit growth in import volumes of high-value interventional devices expected